About Corridor Pharmaceuticals

What does Corridor Pharmaceuticals do?

Corridor Pharmaceuticals is a provider of platform-based pulmonary and critical care therapeutics, developing and commercializing small-molecule inhibitors of arginase to address elevated arginase levels, targeting arginase—an enzyme that competes with endothelial nitric oxide synthase for l-arginine and leads to ornithine production.

Who are Corridor Pharmaceuticals's competitors?

Corridor Pharmaceuticals's competitors and similar companies include Rockwell Medical, Orbis Biosciences, Neutrolis, Oxford Biomedica, and Genzyme.

Where is Corridor Pharmaceuticals headquartered?

Corridor Pharmaceuticals is headquartered in United States.

How many employees does Corridor Pharmaceuticals have?

Corridor Pharmaceuticals has 1,000 employees 🔒.

When was Corridor Pharmaceuticals founded?

Corridor Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is Corridor Pharmaceuticals in?

Corridor Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Corridor Pharmaceuticals

Who are the top strategic acquirers in Corridor Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Corridor Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Corridor Pharmaceuticals?

Top strategic M&A buyers groups and sectors for Corridor Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Corridor Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Corridor Pharmaceuticals's sector and industry vertical?

Top PE firms investing in Corridor Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Corridor Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Corridor Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Corridor Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Corridor Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Corridor Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Corridor Pharmaceuticals?

The key public trading comparables and valuation benchmarks for Corridor Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Corridor Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Corridor Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Corridor Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Corridor Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Corridor Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Corridor Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.